Posted inBiotechnology JPM25: AbbVie pens $1B deal for Simcere’s phase 1 T-cell engager January 13, 2025 T-cell engagers have been hot property in recent months, so it’s only right that one the biggest deals to kick…
Posted inMedical Technology JPM25: Regeneron, Illumina and more back Truveta for 10M genome sequencing project January 13, 2025 Illumina and Regeneron are taking stakes in health data company Truveta to help fund research that may dwarf the efforts…
Posted inBiotechnology JPM25: Eli Lilly strikes $2.5B Scorpion buyout in twist to breast cancer tale January 13, 2025 Eli Lilly is reenergizing its attempt to challenge Novartis and Roche for a breast cancer market, kicking off the J.P. Morgan…
Posted inMedical Technology JPM25: Guardant Health posts 31% sales gain as cancer blood tests expand January 13, 2025 SAN FRANCISCO—In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million…
Posted inBiotechnology Exploring the Impact of Obesity on Childhood Cancer Survival Rates January 13, 2025 A groundbreaking retrospective study published in the esteemed journal CANCER reveals concerning data regarding childhood cancer patients who are obese…
Posted inBiotechnology Telix continues shopping spree with $45M purchase of ImaginAb’s preclinical drugs, facility January 13, 2025 Telix Pharmaceuticals’ expansion phase shows no sign of running out yet, with the Australian radiopharma company paying $45 million in…
Posted inBiotechnology Blueprint ends work on clinical-stage CDK2 inhibitor but pushes on in breast cancer January 13, 2025 Blueprint Medicines is cutting funding to its clinical-stage CDK2 inhibitor even as the Ayvakit-maker pushes forward with similar preclinical breast…
Posted inBiotechnology Epigenetic biotech raises bumper round to the Tune of $175M to fund entry into clinic January 13, 2025 Investors clearly appreciate the song that Tune Therapeutics is singing, handing over $175 million in series B funds as the…
Posted inGenetics JPM: More “Smaller, Smarter” M&A Deals Expected in 2025, EY Predicts January 13, 2025 SAN FRANCISCO—Biopharma merger-and-acquisition (M&A) transactions are expected to grow in number, but not as much by dollar value, during 2025,…
Posted inBiotechnology Key Genetic Discoveries by HKU Ecologists Enhance Conservation Efforts for Iconic Cockatoo Species January 12, 2025 Ecologists at the University of Hong Kong (HKU) have unveiled groundbreaking discoveries that promise to reshape conservation strategies for two…